Thrombolysis in pediatric stroke study (original) (raw)
Use of tPA in a 16 Year Old with Acute MCA Stroke
Rodica Elena Petrea
Journal of Pediatric Neurology and Medicine, 2017
View PDFchevron_right
Emergence of the primary pediatric stroke center: Impact of the thrombolysis in pediatric stroke trial
Michael Rivkin
2014
View PDFchevron_right
Successful Intravenous Thrombolysis in a 14-Year-Old Boy With Ischemic Stroke
Marisa Vieira
Pediatric Emergency Care, 2011
View PDFchevron_right
Practical Model-Based Dose Finding in Early-Phase Clinical Trials: Optimizing Tissue Plasminogen Activator Dose for Treatment of Ischemic Stroke in Children
Collin Hovinga
Stroke, 2008
View PDFchevron_right
Management of acute stroke in the paediatric age group
Samar Muwakkit
Practical Neurology, 2005
View PDFchevron_right
Safety of Protocol Violations in Acute Stroke tPA Administration
muhammad alvi
Journal of Stroke and Cerebrovascular Diseases, 2014
View PDFchevron_right
Treating Acute Stroke Patients With Intravenous tPA The OSF Stroke Network Experience
David Wang
2000
View PDFchevron_right
Endovascular Therapies for Acute Ischemic Stroke in Children
Avra Laarakker
Stroke, 2017
View PDFchevron_right
AHA/ASA Science Advisory Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association
Jeffrey L Saver
View PDFchevron_right
Hemorrhage rates and outcomes when using up to 100 mg intra-arterial t-PA for thrombolysis in acute ischemic stroke
Yousef Mohammad
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2010
View PDFchevron_right
Regional Pediatric Acute Stroke Protocol: Initial Experience During 3 Years and 13 Recanalization Treatments in Children
Augustin ozanne
Stroke, 2017
View PDFchevron_right
The Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Caspian Journal of Neurological Sciences (CJNS)
View PDFchevron_right
Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia
Oleg Chernyshev
Neurology, 2010
View PDFchevron_right
Repeat intravenous r-tPA administration four days after initial thrombolytic therapy for recurrent ischemic stroke: A case report and review of literature
Aimen Vanood
Interdisciplinary Neurosurgery, 2021
View PDFchevron_right
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
Andrew Southerland
Vascular Health and Risk Management, 2014
View PDFchevron_right
Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator: A Science Advisory From the American Heart Association/American Stroke Association
Jeffrey L Saver, Edward Jauch
Stroke, 2009
View PDFchevron_right
Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator
Jeffrey L Saver
Stroke, 2012
View PDFchevron_right
Thrombolysis in Acute Childhood Stroke: Design and Challenges of the Thrombolysis in Pediatric Stroke Clinical Trial
Derek Stephens
Neuroepidemiology, 2009
View PDFchevron_right
Controversies in Acute Stroke Treatment
Victoria Swatzell, Anne Alexandrov
AACN Advanced Critical Care, 2012
View PDFchevron_right
Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Peter Marx
Stroke, 2001
View PDFchevron_right
Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial
rashmi kothari
2000
View PDFchevron_right
Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
Philippe Desfontaines
Acta neurologica Belgica
View PDFchevron_right
Acute Ischemic Stroke in a Child Successfully Treated with Thrombolytic Therapy and Mechanical Thrombectomy
João Xavier
Case Reports in Neurology, 2019
View PDFchevron_right
Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
Jaime Alvarez Polanía
Cureus
View PDFchevron_right
Urgent Clinical Challenges in Children With Ischemic Stroke
Anthony Chan
Stroke, 2006
View PDFchevron_right
Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Maxim Hammer
Archives of Neurology, 2004
View PDFchevron_right
Ischemic Stroke and Excellent Recovery After Administration of Intravenous Tissue Plasminogen Activator
Lawrence Morton
Pediatric Neurology, 2008
View PDFchevron_right
Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders
K. Bdeir, Vladimir Muzykantov
Journal of Neurochemistry, 2010
View PDFchevron_right
Treatment of acute ischemic stroke with recombinant tissue plasminogen activator: practice pattern among neurologists and physicians
Yaseen Mohammed
International Journal of Basic & Clinical Pharmacology, 2016
View PDFchevron_right
Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Ching-kuan Liu
Cerebrovascular Diseases, 2006
View PDFchevron_right